Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOURMALINE-MM1: Ixazomib + Len/Dex in RRMM
NCT01564537Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Takeda. Started Aug 2012; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01564537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01564537.